Viewing Study NCT00099892


Ignite Creation Date: 2025-12-24 @ 3:49 PM
Ignite Modification Date: 2025-12-25 @ 1:56 PM
Study NCT ID: NCT00099892
Status: COMPLETED
Last Update Posted: 2017-08-02
First Post: 2004-12-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy and Safety of Vildagliptin in Combination With Metformin in Patients With Type 2 Diabetes
Sponsor: Novartis Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module